N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142675 |
| CAS No | NA |
| Mol.F. | C12H8ClN3O3 |
| Mol.Wt. | 277.66 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142676 |
| CAS No | NA |
| Mol.F. | C15H10ClN3O3 |
| Mol.Wt. | 315.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142677 |
| CAS No | NA |
| Mol.F. | C16H15ClN2O4S |
| Mol.Wt. | 366.8g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142678 |
| CAS No | NA |
| Mol.F. | C16H15ClN2O4S |
| Mol.Wt. | 366.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142679 |
| CAS No | NA |
| Mol.F. | C15H15ClN2O3S |
| Mol.Wt. | 338.81 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142680 |
| CAS No | NA |
| Mol.F. | C15H15ClN2O3S |
| Mol.Wt. | 338.81 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142681 |
| CAS No | NA |
| Mol.F. | C17H23N3O5 |
| Mol.Wt. | 349.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142682 |
| CAS No | NA |
| Mol.F. | C11H15N3O5 |
| Mol.Wt. | 269.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142683 |
| CAS No | NA |
| Mol.F. | C12H17N3O5 |
| Mol.Wt. | 283.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142684 |
| CAS No | NA |
| Mol.F. | C11H15N3O5 |
| Mol.Wt. | 269.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142685 |
| CAS No | NA |
| Mol.F. | C11H15N3O5 |
| Mol.Wt. | 269.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142686 |
| CAS No | NA |
| Mol.F. | C12H17N3O5 |
| Mol.Wt. | 283.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142687 |
| CAS No | NA |
| Mol.F. | C10H12BrN3O5 |
| Mol.Wt. | 334.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142688 |
| CAS No | NA |
| Mol.F. | C13H17N3O6 |
| Mol.Wt. | 311.29 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142689 |
| CAS No | NA |
| Mol.F. | C10H13N3O4 |
| Mol.Wt. | 239.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142690 |
| CAS No | NA |
| Mol.F. | C10H12BrN3O5 |
| Mol.Wt. | 334.13 g/mol |
| INV STATUS | In Stock |